Completed NA INTERVENTIONAL 2-arm NCT01740219

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches (CRUZA)

Promoting the Utilization of Cancer Early Detection Methods Among Latinos in Church: a Faith-based Approach

Sponsor: Dana-Farber Cancer Institute

Conditions Cancer

Interventions Capacity Enhancement Standard Dissemination

Updated 7 times since 2017 Last updated: Jun 18, 2019 Started: Sep 30, 2011 Primary completion: Sep 30, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cancer and is currently completed. Dana-Farber Cancer Institute leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jul 2019 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jun 2018 — Jul 2019 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dana-Farber Cancer Institute
University of Massachusetts, Boston

Data source: Dana-Farber Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States
• Medford, United States